CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.
Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7.
Cancer Immunol Res. 2020.
PMID: 32265229